Patent · US Active

Method of treating urolithiasis

US11903954B2 · kind B2 · utility

0Cited by
6References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 2, 2022
Grant dateFeb 20, 2024
Priority date
Expiry dateAug 2, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/663
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides phospholipid-containing compounds, pharmaceutical compositions and microspheres that exhibit high affinity for mineralized metals. The present disclosure also provides strategies for using said compounds, compositions and microspheres in the treatment of nephrolithiasis or kidney stone disease, and methods of manufacturing and preparing said compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.